Lipid nanoparticles: A modern formulation approach in topical drug delivery systems.

A. Hajare,S. Mali,Amita A. Ahir,Jyoti D. Thorat,S. Salunkhe,S. Nadaf,N. Bhatia
Abstract:To overcome these limitations of polymeric nanoparticles, lipids have been put forward as an alternative carrier, particularly for lipophilic pharmaceuticals.lipid nanoparticles are known as solid lipid nanoparticles (SLNs) and Nanostructured lipid carriers, which are attracting wide attention of formulators world-wide. SLNs and NLCs are colloidal carriers developed in the last decade as an alternative system to the existing traditional carriers (emulsion, liposomes and polymeric nanoparticles).Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) are composed of a solid matrix once they are derived from o/w emulsions simply replacing the liquid lipid (oil) by a lipid being solid both at room and body temperature.The important parameters which need to be evaluated for the SLNs are, particle size, size distribution kinetics (zeta potential), degree of crystallinity and lipid modification (polymorphism), coexistence of additional colloidal structures (micelles, liposome, super cooled, melts, drug nanoparticles), time scale of distribution processes, drug content, in vitro drug release and surface morphology.Lipid carriers has bright future, because of their intrinsic property to improve the bioavailability of lipophilic drugs with low aqueous solubility. SLN and NLC offers an economical and patient-friendly device for administration of drugs by topical routes.
What problem does this paper attempt to address?